Week 253 Review - The gradual slide continues, and Ilika is gone

Hardly anything happened this week. Most shares slipped a little and very few gained. OPTI:Optibiotix lost 2p which accounted for £2,200 of the £2,646 slide. The deficit between cost and value widened to £34,424 and the overall portfolio value dropped to £81,176.

Biggest faller was my newest share and not a great feeling for my magic formula experiment. APAX:Apax Global Alpha dropped 6%, although I noticed some very odd behaviour of the share price all week, with a big spread during the day tending to close up again at the end. It was hammered on Thursday and is now 10% down.

TRMR:Tremor was the only other big loser, dropping 5% to go 52% down in my trading account.

Share of the Week is IQE:IQE which published a really good trading update. It was so good I'm hoping the climb will continue and we'll end up back around the 100p range. This week it went up 4% which was the biggest rise I managed from anything. My ISA holding was meant to be a short term quick win, and I bought them at 75p thinking it was a steal. 100p would give me a 30% profit which I would take, as they were not meant to be a long term holding. My trading account holding was purchased at 101p so I need a more substantial rise to get anything out of that. I may very well flog them for a loss if it looks like they'll never get there. My SIPP holding is 131p, so they will be for the very, very long term and the dividend.

The third week in a row that I've had a medium sized fall, which is taking us dangerously close to the orange line.

Still above the trend line so there's hope.

Here's the performance of the ISA and share accounts

			Weekly Change
Cash	£14.63		-£89.82
Portfolio cost	£60,070.42		+£242.63
Portfolio sell value (bid price-commission)	£40,550.11	(-32.5%)	-£1,267.07
Potential profits	£0		+£0
Yr 5 Dividends	£0.85		+£0
Yr 5 Profit from sales	£-14.48		+£152.80
Yr 5 Average monthly cash profit	-£4.92	(-0.1%)	+£15.19
Total Dividends	£1,343.15		+£0
Total Profit from sales	£20,376.93		+£152.80
Average monthly cash profit	£368.09	(7.4%)	+£1.17
(Sold stocks profit + Dividends - Fees  / Months)
Performance/Injection	11.2%		+0%
Compound performance	54%		+0%

I sold my 1,600 IKI:Ilika shares for 54.4p after buying them for 43.54369p and made £152.80 (21.2%) profit. This was really great, as I've been moaning about how rubbish the company is for ages and I didn't think I'd ever get to make a profit. Knowing my luck they will fly now, and I wish them all the best as their technology is great. I just have severe doubts about their ability to commercialise it and turn a profit.

Unfortunately the profit wasn't enough to take my year 5 performance into positive territory, but it did improve by £15 a month and one more sale should see me in the black. I tried to resist, but couldn't stop myself buying 1,672 more OPTI:Optibiotix shares at 56p, costing £948.27. Given that my average is around 65p, I had to take a chance to bring that down a little. I was also convinced they were due a spike at the end of the week after a tree shake to just below support the day before. Unfortunately I was dead wrong.

The purchase takes my overall holding in OPTI:Optibiotix to 111,661 shares bought at an average price of 64.53p and costing £72,468.09. That's 62% of my portfolio cost. Each 1p change in share price is worth £1,116. It's currently losing £14,440 which makes me sad.

The profit from the sale was so measly when spread over 5 years it didn't move the percentage by even 0.1.

Just above the injection line, which is some small comfort.

The trend line isn't that steep really, but the fact it's still downwards is troubling. At least we're still the right side of it.

The SIPP looks like this after week 237

			Weekly Change
Cash	£29.81		+£0
Portfolio cost	£52,946.27		+£0
Portfolio sell value (bid price - commission)	£38,990.09	(-26.4%)	-£1,347.08
Potential profits	£66.28		-£42.76
Yr 5 Dividends	£0		+£0
Yr 5 Interest	£0.03		+£0
Yr 5 Profit from sales	£0		+£0
Yr 5 Average monthly cash profit	-£14.57	(-0.3%)	+£0.52
Total Dividends	£1,899.24		+£0
Total Interest	£0.20		+£0
Total Profit from sales	£12,549.10		+£0
Average monthly cash profit	£254.29	(5.8%)	-£1.08
(Sold stocks profit + Dividends - Fees / Months)
Performance/Injection	8.7%		+0%
Compound performance	40%		+0%

Very little happened. Potential profits fell, with only JLP:Jubileee Metals and FXPO:Ferrexpo still in profit as SBTX:SkinBioTherapeutics went back to loss. All of those shares dropped a bit, so £42 was knocked off paper profits. OPTI:Optibiotix accounted for most of the drop in value, but CAML:Central Asia Metals also fell and had an impact.

Still a bit of a buffer to the orange line.

In 3 weeks we'll lose anything above zero and will have been in the red for a whole year. I'm not selling anything and getting precious few dividends, so it's all a bit rubbish. I hope my move to the magic formula experiment will turn things around. I'll have my first dividend payment in a few weeks, so it's already bearing fruit.

Here's the trading portfolio after week 203

			Weekly Change
Cash	£186.37		+£0
Portfolio cost	£2,354.11		+£0
Portfolio sell value (bid price - commission)	£1,405.80	(-40.3%)	-£32.30
Potential profits	£0		+£0
Year 4 Dividends	£13.20		+£0
Year 4 Profit	£320.95		+£0
Yr 4 Average monthly cash profit	£30.81	(15.7%)	-£0.67
Dividends	£47.92		+£0
Profit from sales	£256.66		+£0
Average monthly cash profit	£6.50	(3.3%)	-£0.03
(Sold stocks profit + Dividends - Fees  / Months)
Performance/Injection	3.6%		+0%
Compound performance	14%		+0%

Back to nothing much happening with this account, as SBTX:SkinBioTherapeutics failed miserably to take off to 20p like I expected. It's only 7% down, so it could make that up in a day the way things tend to move with this share. The nearest other share to profit is CAML:Central Asia Metals, but that's still down 41%. The announcement of dividend re-reinstatement would give them a massive boost. If FXPO:Ferrexpo can do it I don't see why CAML can't, especially as none of their mines have been impacted by Coronavirus. It's sensible that they suspended it, but when they are confident in final results surely they should re-instate.

It's rather frustrating that LION:Lionsgold (now TALY:Tally) was bought for £345 as I'd made a loss elsewhere and didn't have cash to make it up to £500. It would be great to flog that and get back to a £2,500 cost price, but they are still suspended. I'm not even certain if they will ever re-list. From the bulletin boards it sounds as if there are technical problems with their credit card resulting in people being over charged, so it's not looking very promising.

I do believe that line is almost flat! Just need to lift it up by £1,000 now...

Despite Thursday's big drop, the virtual magic formula account improved from -15.2% to -15.07%, which is quite a surprise. Only 4 shares are in profit, but many of the losses are smaller. CARD:Card Factory, VTY:Vistry Group and ITV:ITV are by far the worst performers, with PLUS:Plus 500, FXPO:Ferrexpo and IGG:IG Group way ahead.

My dream for next week is a SweetBiotix announcement from OPTI:Optibiotix, re-instatement of the dividend for CAML:Central Asia Metals, a trading update from JLP:Jubilee Metals, and IQE:IQE going on a roll. Even just one of those would be nice...